Erudio Healtherudio.com
Indication
Oligometastatic cancer
2 HCP commentary reports on clinical trials in Oligometastatic cancer. Each report covers what clinicians said in public about one trial, with the source behind every view.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| EXTEND-OP NCT06367972 · M.D. Anderson Cancer Center | oligoprogressive metastatic disease | Phase 2/Phase 3 | 25 | 3 | Focused 15 from 3 confirmed clinicians | Nov 1, 2026 | Preview |
| TRITONS NCT06587490 · University of California, San Diego | oligometastatic cancer | Phase 3 | 38 | 7 | Focused 28 from 7 confirmed clinicians | Oct 30, 2026 | Preview |